Taltz B (ixekizumab) Eli Lilly Canada Inc - Taltz is used for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates ... of moderate to deep neuromuscular blockade ...

Patients with specific dermatological immune-mediated inflammatory diseases are not at increased risk of developing severe COVID-19.

indications and dosages of Remdantry will remain the same as that of Inflectra, which was originally approved by the Health Canada for the treatment of rheumatoid arthritis (RA), plaque psoriasis ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

U.S. consumer confidence slid backward this month, reflecting expectations that tariffs proposed by the Trump administration on goods imports will lead to rising prices. The University of Michigan ...

Some evidence suggests a higher risk of liver disease with psoriasis. Certain psoriasis treatments can cause liver toxicity, but the two conditions also share common risk factors, which may ...

[1] "Chronic inflammatory diseases such as plaque psoriasis and psoriatic arthritis place significant burden on patients," said Mark G. Lebwohl*, MD, Icahn School of Medicine at Mount Sinai ...

Original Medicare covers most medically necessary treatments for rheumatoid arthritis (RA), including biologics like adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade, Inflectra), and ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...